MAPT and Alzheimer disease: Apart from accurate diagnosis of AD, tau PET is likely to play an important role in future therapeutic trials both in terms of subject stratification on entry and measuring longitudinal deposition of tau and any changes in the rate of accumulation or reduction in pathology may be used as outcomes in therapeutic trials [195].